The global progressive pulmonary fibrosis treatment market a chronic, progressive, and irreversible lung condition—is poised for significant expansion, fueled by a growing patient population suffering from interstitial lung diseases (ILDs), which remains the leading cause of PPF worldwide. A newly released market report projects that the PPF treatment market will grow at a CAGR of …